RiverVest Venture Fund IV, L.P., 10% Owner at Xilio Therapeutics, Inc. (XLO), bought 609,324 shares at $16.00 ($4.0M) on 2021-10-26, disclosed to the SEC on 2021-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 359,324 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $6.56 avg | 609,324 | $4.0M | 100% |